西安诺和达生物科技有限公司
+86 13662665103 Mon–Fri, 09:00–18:00 GMT+8 Contact Us sales@nhdbio.com
Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司

Quote list

Review quantities before sending your request.

View full quote listContinue browsing productsThis is an enquiry list, not a checkout. No payment is taken.
 Request an Account

Literature and evidence database

Find the source, the model and the boundary.

Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.

Explore the library Compare products

Product evidence maps

A focused source set for each product.

AOD-9604 Evidence MapA source-linked map of clinical-development, preclinical, analytical and FDA compounding-review records for AOD-9604.BPC-157 Evidence MapA source-linked map that keeps animal, cell, review and FDA compounding records separate for BPC-157.CJC-1295 DAC Evidence MapA source-linked map of human pharmacology, molecular-identity, analytical and FDA compounding records for CJC-1295 with DAC.Retatrutide Evidence MapA source-linked map separating peer-reviewed human trials, trial registries, sponsor status reports, mechanism studies and regulatory context for retatrutide.Tirzepatide Evidence MapA source-linked map of controlled human trials, FDA labeling, mechanism records and material-identity boundaries for tirzepatide.

Search and filter

Evidence records

Narrow the records by product, year or study model. Open each source to check its results and limitations.

195 matching records · showing 151–180

Last editorial refresh: September 2, 2026

Editorial methodology

How records are classified

Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.

Read the full editorial, AI-assistance and correction policy →

Regulatory / authoritative

Labels and databases supporting regulatory status, formulation or chemical identity.

Level 1–2 human evidence

Controlled trials, systematic reviews and other clinical records with population-specific interpretation.

Level 3–4 experimental evidence

Animal, cell, analytical and mechanistic records that cannot establish human outcomes.

Context records

Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.

Use the records

Turn evidence into a structured comparison.

Comparison centerResearch glossaryLaboratory calculators